OBI PHARMA, INC.
Area: Pharmaceutical and Medical Devices
Booth No: M305
Website: http://www.obipharma.com
Exhibitor Profile
OBI Pharma is a clinical-stage oncology company founded in 2002 and headquartered in Taiwan. The company develops innovative cancer therapeutics focused on next-generation antibody-drug conjugates (ADCs). Our proprietary Obrion® platform integrates advanced conjugation and linker technologies, including GlycOBI®, GlycOBI DUO®, EndoSymeOBI®, HYPrOBI®, and ThiOBI®. Pipeline includes mon/bispecific, and dual-payload ADCs, along with OBI-3424, an AKR1C3-targeted prodrug for cancer treatment.
Exhibit Products
Exhibitors you may be interested in
Highest Rated